Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Julia Rawlings

Concepts (54)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Safety Management
2
2018
112
0.660
Why?
Patient Safety
2
2018
287
0.560
Why?
Pharmacy Service, Hospital
1
2018
89
0.530
Why?
Organizational Culture
1
2018
138
0.530
Why?
Remote Consultation
1
2022
46
0.190
Why?
Drug Overdose
1
2022
322
0.150
Why?
Pharmacy
1
2017
31
0.130
Why?
Pharmaceutical Services
1
2017
81
0.130
Why?
Benchmarking
1
2017
176
0.120
Why?
Opioid-Related Disorders
1
2022
483
0.120
Why?
Pharmacists
1
2017
246
0.110
Why?
Colchicine
1
2012
24
0.100
Why?
Gout Suppressants
1
2012
17
0.100
Why?
Gout
1
2012
33
0.100
Why?
Hematologic Diseases
1
2012
62
0.100
Why?
Chemical and Drug Induced Liver Injury
1
2012
132
0.090
Why?
Renal Insufficiency
1
2012
150
0.090
Why?
Attitude of Health Personnel
1
2018
1098
0.080
Why?
Cross-Sectional Studies
2
2018
5075
0.080
Why?
Delivery of Health Care
1
2017
898
0.080
Why?
Surveys and Questionnaires
2
2018
5415
0.070
Why?
Sumatriptan
1
1999
8
0.040
Why?
Health Maintenance Organizations
1
1999
97
0.040
Why?
Colorado
2
2022
4404
0.040
Why?
Migraine Disorders
1
1999
101
0.030
Why?
Pharmacies
1
2017
36
0.030
Why?
Pain
1
2022
787
0.030
Why?
Analgesics, Opioid
1
2022
913
0.030
Why?
Humans
5
2022
129625
0.030
Why?
Practice Patterns, Physicians'
1
2022
1271
0.030
Why?
Counseling
1
2017
386
0.030
Why?
Cytochrome P-450 CYP3A Inhibitors
1
2012
18
0.020
Why?
Cytochrome P-450 CYP3A
1
2012
88
0.020
Why?
Insurance, Health, Reimbursement
1
2012
94
0.020
Why?
Drug Interactions
1
2012
395
0.020
Why?
Communication
1
2017
838
0.020
Why?
Enzyme Inhibitors
1
2012
827
0.020
Why?
United States
2
2022
13871
0.020
Why?
Prevalence
1
2012
2564
0.020
Why?
Electronic Health Records
1
2012
973
0.010
Why?
Case-Control Studies
1
2012
3378
0.010
Why?
Cohort Studies
1
2012
5426
0.010
Why?
Efficiency
1
1999
91
0.010
Why?
Health Services
1
1999
99
0.010
Why?
Statistics, Nonparametric
1
1999
419
0.010
Why?
Cost of Illness
1
1999
277
0.010
Why?
Young Adult
1
2012
12455
0.010
Why?
Middle Aged
2
2012
31136
0.010
Why?
Adult
2
2012
35599
0.010
Why?
Patient Satisfaction
1
1999
633
0.010
Why?
Aged
1
2012
22061
0.010
Why?
Male
2
2012
63670
0.010
Why?
Female
2
2012
68734
0.010
Why?
Quality of Life
1
1999
2688
0.000
Why?
Rawlings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)